{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:44:56Z","timestamp":1777463096116,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejmech.2017.03.042","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T13:49:59Z","timestamp":1490363399000},"page":"268-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia"],"prefix":"10.1016","volume":"133","author":[{"given":"Anil M.","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debnath","family":"Bhuniya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha","family":"De","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavesh","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod P.","family":"Vyavahare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh H.","family":"Kurhade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin R.","family":"Kandalkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshav P.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balasaheb S.","family":"Kobal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul D.","family":"Kaduskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujay","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Chaturvedi Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol A.","family":"Raje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyanarayana","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayasagar","family":"Gundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamsi","family":"Madgula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1695-8198","authenticated-orcid":false,"given":"Suhas","family":"Tambe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad","family":"Shitole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhananjay","family":"Umrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata P.","family":"Palle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasim A.","family":"Mookhtiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.03.042_sref1","unstructured":"For recent reviews on glucokinase activators, see following:"},{"issue":"2","key":"10.1016\/j.ejmech.2017.03.042_bib1a","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jdi.12294","article-title":"Present status of clinical deployment of glucokinase activators","volume":"6","author":"Nakamura","year":"2015","journal-title":"J.\u00a0Diabetes Investig."},{"issue":"8","key":"10.1016\/j.ejmech.2017.03.042_bib1b","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/13543776.2014.918957","article-title":"A\u00a0patent review of glucokinase activators and disruptors of the glucokinase\u2013glucokinase regulatory protein interaction: 2011-2014","volume":"24","author":"Filipski","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.ejmech.2017.03.042_bib1c","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1517\/13543776.2011.542413","volume":"21","author":"Sarabu","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2017.03.042_bib1d","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2850","volume":"8","author":"Matschinsky","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.03.042_bib1e","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.drudis.2009.05.013","volume":"14","author":"Pal","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2017.03.042_bib1f","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.17.2.145","volume":"17","author":"Coghlan","year":"2008","journal-title":"Expt. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2017.03.042_bib1g","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ddstr.2007.10.009","volume":"4","author":"Sarabu","year":"2007","journal-title":"Drug Discov. Today Ther. Strateg. Metabolic\/endocrine Syst."},{"key":"10.1016\/j.ejmech.2017.03.042_bib1h","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diabetes.47.3.307","article-title":"Pancreatic \u03b2-cell glucokinase closing the gap between theoretical concepts and experimental realities","volume":"47","author":"Matschinsky","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2017.03.042_bib2","doi-asserted-by":"crossref","first-page":"14105","DOI":"10.1074\/jbc.M413146200","article-title":"Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young","volume":"280","author":"Gloyn","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_sref3","unstructured":"For gain of enzyme function see the following:"},{"key":"10.1016\/j.ejmech.2017.03.042_bib3a","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2337\/diabetes.51.4.1240","article-title":"The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy","volume":"51","author":"Christesen","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2017.03.042_bib3b","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2337\/diabetes.52.9.2433","article-title":"Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations","volume":"52","author":"Gloyn","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2017.03.042_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/humu.10277","article-title":"Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy","volume":"22","author":"Gloyn","year":"2003","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.ejmech.2017.03.042_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1074\/jbc.274.1.305","article-title":"Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using cre recombinase","volume":"274","author":"Postic","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib5a","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/diab.46.1.11","article-title":"Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight","volume":"46","author":"Hariharn","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2017.03.042_bib5b","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-002-0881-y","article-title":"Improved metabolic disorders of insulin receptor-deficient mice by transgenic overexpression of glucokinase in the liver","volume":"45","author":"Jackerott","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2017.03.042_bib5c","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2337\/db08-1119","article-title":"Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats","volume":"58","author":"Torres","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2017.03.042_sref6","unstructured":"For glucokinase activators effective as antihyperglycemic agents in animal see the following:"},{"key":"10.1016\/j.ejmech.2017.03.042_bib7a","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1126\/science.1084073","article-title":"Allosteric activators of glucokinase: potential role in diabetes therapy","volume":"301","author":"Grimsby","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.03.042_bib7b","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.bmcl.2004.12.083","article-title":"Glucokinase-activation ureas","volume":"15","author":"Castelhano","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.03.042_bib7c","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.bmcl.2006.02.022","article-title":"Design of a potent, soluble glucokinase activator with excellent in\u00a0vivo efficacy","volume":"16","author":"McKerrecher","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.03.042_bib7d","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1016\/j.bmcl.2009.08.064","article-title":"Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators","volume":"19","author":"Iino","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.03.042_bib7e","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/j.bmcl.2010.08.029","article-title":"2,3-Disubstituted acrylamides as potent glucokinase activators","volume":"20","author":"Sidduri","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.03.042_bib8","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1021\/jm100039a","article-title":"Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2r)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)","volume":"53","author":"Haynes","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2017.03.042_bib9a","first-page":"S23","article-title":"A\u00a0novel glucokinase activator RO4389620 improved fasting and postprandial plasma glucose in type 2 diabetic patients","volume":"51","author":"Zhi","year":"2008","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2017.03.042_bib9b","first-page":"S372","article-title":"Phase I assessments of a novel glucokinase activator RO4389620 in healthy male volunteers","volume":"51","author":"Zhai","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2017.03.042_bib9c","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1210\/jc.2010-1041","article-title":"Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study","volume":"95","author":"Bonadonna","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2017.03.042_bib9d","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jcph.589","article-title":"Effects of piragliatin, a glucokinase activator, on fasting and postprandial plasma glucose in patients with type 2 diabetes mellitus","volume":"56","author":"Zhi","year":"2016","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.03.042_bib10a","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00125-007-0646-8","article-title":"Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions","volume":"50","author":"Fyfe","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2017.03.042_bib10b","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1021\/jm8003202","article-title":"SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1","volume":"51","author":"Bertram","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2017.03.042_bib11","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/en.2005-0377","article-title":"A\u00a0novel glucokinase activator modulates pancreatic islet and hepatocyte function","volume":"146","author":"Efanov","year":"2005","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.ejmech.2017.03.042_bib12a","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/dc11-1200","article-title":"Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes","volume":"34","author":"Meininger","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2017.03.042_bib12b","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/op200068c","article-title":"Large-scale synthesis of potent glucokinase activator MK-0941 via selective O-Arylation and O-Alkylation","volume":"15","author":"Yoshi","year":"2011","journal-title":"Org. Process Res. Dev."},{"issue":"6","key":"10.1016\/j.ejmech.2017.03.042_bib12c","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1124\/mol.111.074401","volume":"80","author":"Eiki","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.03.042_bib13a","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1039\/c3md20368a","article-title":"Optimising pharmacokinetics of glucokinase activators with matched triplicate design sets \u2013 the discovery of AZD3651 and AZD9485","volume":"4","author":"Warning","year":"2013","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2017.03.042_bib13b","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1039\/c3md20367k","article-title":"Matched triplicate design sets in the optimisation of glucokinase activators \u2013 maximising medicinal chemistry information content","volume":"4","author":"Warning","year":"2013","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2017.03.042_bib13c","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1039\/c2md20077e","article-title":"Property based optimisation of glucokinase activators \u2013 discovery of the phase IIb clinical candidate AZD1656","volume":"3","author":"Warning","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2017.03.042_bib14a","doi-asserted-by":"crossref","first-page":"e97139","DOI":"10.1371\/journal.pone.0097139","article-title":"The hepatoselective glucokinase activator PF-4991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats","volume":"9","author":"Erion","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2017.03.042_bib14b","series-title":"The Hepatoselective Glucokinase Activator (GKA) PF-04991532, Lowers HbA1c after 12-weeks of Dosing in Patients with Type 2 Diabetes (T2DM). 73rd American Diabetes Association Meeting","author":"Kazierad","year":"2013"},{"key":"10.1016\/j.ejmech.2017.03.042_bib14c","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/jm2014887","article-title":"Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus","volume":"55","author":"Pfefferkorn","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib14d","unstructured":"Pfefferkorn, J. A.; Guzman-Perez, A.; Litchfield, J.; Aiello, R.; Treadway, J. L.; Pettersen, J.; Minich, M. L.; Filipski, K. J.; Jones, C. S.; Tu, M.; Aspnes, G.; Risley, H.; Wright, S. W.; Li, J. \u2013C.; Bian, J.; Benbow, J.; Dow, R. L.; Bourassa, P.; D'Aquila, T.; Baker, L.; Barucci, N.; Robertson, A.; Bourbonais, F.; Derksen, D. R.; MacDougall, M.; VanVolkenburg, M.; Cabrera, O.; Chen, J.; Lapworth, A. L.; Landro, J. A.; Atkinson, K.; Tan, B.; Yao, L.; Kosa, R. E.; Haddish-Berhane, N.; Feng, B.; Duignan, D. B.; El-Kattan, A.; Berliner, M. A.; Dunetz, J. R.; Murdande, S.; Liu, S.; Ammirati, M.; Knafels, J. 241st American Chemical Society National Meeting, Anaheim, CA, 27-31 March, 2011."},{"key":"10.1016\/j.ejmech.2017.03.042_sref9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acsmedchemlett.6b00145","article-title":"5-Alkyl-2-urea-Substituted pyridines: identification of efficacious glucokinase activators with improved properties","volume":"7","author":"Kohn","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.03.042_bib15b","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/acs.jmedchem.5b01367","article-title":"Discovery and structure-guided optimization of diarylmethanesulfonamide disrupters of glucokinase-glucokinase regulatory protein (GK-GKRP) binding: strategic use of a N \u2192 S (nN \u2192 \u03c3*S-X) interaction for conformational constraint","volume":"58","author":"Pennington","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib16","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1073\/pnas.83.7.1998","article-title":"Differential expression and regulation of the glucokinase gene in liver and islets of langerhans","volume":"83","author":"Iynedjian","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.03.042_bib17a","series-title":"TTP399, a Novel, Liver Selective Glucokinase Activator: Results from a 10 Day Pilot Study in Patients with Type 2 Diabetes Mellitus (T2DM) Na\u00efve to Drug. Presented at 76th American Diabetes Association Meeting","author":"Valcarce","year":"2016"},{"key":"10.1016\/j.ejmech.2017.03.042_bib17b","unstructured":"Available from: www.clinicaltrials.gov and www.ttpharma.com."},{"key":"10.1016\/j.ejmech.2017.03.042_bib18a","series-title":"Glucokinase Modulator GKM-001 Improves Glucose Control through Liver-directed\/Pancreas-sparing Action. Presented at Keystone Symposia on Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms Meeting","author":"Hariharan","year":"2012"},{"key":"10.1016\/j.ejmech.2017.03.042_bib18b","series-title":"GKM-001a Glucokinase Modulator with Liver-directed\/Pancreas-sparing Action Improves Glucose Control in Rodent Models with Diabetes without Hypoglycemia Risk or Tachyphylaxis. Presented at 72nd American Diabetes Association Meeting","author":"Mookhtiar","year":"2012"},{"key":"10.1016\/j.ejmech.2017.03.042_bib19","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1021\/jo070907g","article-title":"Chlorotrimethylsilane\u2212Nitrate salts as Oxidants:\u2009 direct oxidative conversion of thiols and disulfides to sulfonyl chlorides","volume":"72","author":"Surya Prakash","year":"2007","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib20a","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1016\/j.bmcl.2011.10.040","article-title":"Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy","volume":"21","author":"Powell","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.03.042_bib20b","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/17425255.4.4.363","article-title":"The role of hepatic transporters in drug elimination","volume":"4","author":"Func","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejmech.2017.03.042_bib20c","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425255.1.3.429","article-title":"Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination","volume":"1","author":"Smith","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejmech.2017.03.042_bib21a","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.str.2004.02.005","article-title":"Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase","volume":"12","author":"Kamata","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2017.03.042_bib21b","series-title":"Glucokinase and Glycemic Disease: from Basics to Novel Therapeutics. Frontiers in Diabetes","first-page":"145","article-title":"Crystal structure of human liver glucokinase bound to a small molecule allosteric activator","volume":"vol. 16","author":"Dunten","year":"2004"},{"key":"10.1016\/j.ejmech.2017.03.042_bib22","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1021\/jm900839k","article-title":"Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes","volume":"52","author":"Bebernitz","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib23","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Richard","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1359-6446(04)03280-5","article-title":"Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability","volume":"9","author":"Nassar","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2017.03.042_bib25","doi-asserted-by":"crossref","first-page":"30479","DOI":"10.1074\/jbc.271.48.30479","article-title":"Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis","volume":"271","author":"Agius","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib26","series-title":"The Models for Assessing Drug Absorption and Metabolism","first-page":"121","article-title":"Culture Rat Hepatocytes","author":"LeCluyse","year":"1996"},{"key":"10.1016\/j.ejmech.2017.03.042_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1107\/S0907444911036729","article-title":"The active conformation of human glucokinase is not altered by allosteric activators","volume":"67","author":"Petit","year":"2011","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.03.042_bib28a","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgern","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.03.042_bib28b","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341730199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341730199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T13:56:18Z","timestamp":1530021378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341730199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":63,"alternative-id":["S022352341730199X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.03.042","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}